Dr Alwin Tan, MBBS, FRACS, EMBA (Melbourne Business School)

Senior Surgeon | Governance Leader | HealthTech Co-founder
Harvard Medical School — AI in Healthcare
Australian Institute of Company Directors — GAICD candidate
University of Oxford — Sustainable Enterprise

Institute for Systems Integrity (ISI)

Executive Summary

Healthcare systems are under growing pressure to demonstrate environmental sustainability. Recycled-content products — particularly plastic-derived textiles — are increasingly presented as evidence of circular progress.

Yet a critical distinction is often blurred:

Recycled is an input claim. Circular is a system outcome.

In healthcare, clinical safety, contamination risks, regulatory constraints, and end-of-life pathways fundamentally shape what circularity can realistically mean. Products that appear sustainable at the label level may still follow linear material flows in practice.

From a systems integrity perspective, the risk is not poor intention — but signal distortion, where visible sustainability metrics obscure underlying lifecycle realities.

The Appeal of Recycled Content

“Made from recycled plastic” is a powerful proposition.

It is:

✔ simple
✔ measurable
✔ reportable
✔ reputationally attractive

Recycled content fits neatly into ESG frameworks and procurement scorecards.

But simplicity can conceal complexity.

A product may contain recycled inputs while:

❌ lacking viable recovery pathways
❌ degrading material value
❌ generating unintended externalities

Circularity cannot be inferred from composition alone.

When Circularity Breaks at the System Level

Circular systems require materials to:

✔ circulate repeatedly
✔ retain functional value
✔ be recoverable at end of use

In packaging streams, PET bottles often benefit from relatively mature collection and recycling systems, including bottle-to-bottle pathways under controlled conditions (Benyathiar et al., 2022).

Textiles operate under different constraints:

• fibre blends
• dyes and finishes
• contamination
• complex sorting
• weak recycling infrastructure

Consequently, many bottle-to-textile flows become:

bottle → textile → waste

rather than:

textile → textile

(SYSTEMIQ, 2023).

The Competition Effect

Redirecting recyclable PET from bottle-to-bottle loops into textiles may weaken higher-value recovery systems.

A product-level sustainability gain can coexist with a system-level circularity loss (Changing Markets Foundation, 2023).

This reflects a common integrity failure:

Optimising visible outcomes while degrading invisible system performance.

Microfibres: Leakage Beyond the Waste Bin

Synthetic textiles shed microfibres during washing and wear.

UNEP has identified textile-derived microfibres as a significant environmental concern and highlights mitigation strategies (UNEP, 2019).

This introduces a further tension:

A recycling initiative may reduce solid waste metrics while increasing diffuse environmental leakage.

Without lifecycle-wide evaluation, sustainability signals may mislead.

Healthcare’s Boundary Condition: Safety

Healthcare differs fundamentally from consumer sectors.

Material choices are constrained by:

🛡 Infection prevention
🛡 Barrier integrity
🛡 Regulatory compliance
🛡 Patient safety

Once textiles are clinically contaminated, recovery options narrow sharply. Disposal pathways frequently default to incineration or landfill (UNEP, 2022; Hasan et al., 2023).

In this context:

End-of-life systems often determine sustainability outcomes more than recycled inputs.

Circularity cannot compromise clinical safety.

Systems Integrity Risks

ISI observes recurring patterns when sustainability initiatives are poorly aligned with operational realities:

❌ Signal distortion
❌ Value degradation
❌ Risk displacement
❌ Circularity theatre

These failures arise when:

• metrics replace mechanisms
• narratives replace lifecycle analysis
• product claims replace system evaluation

Well-intended interventions can destabilise systems when upstream and downstream conditions are ignored.

Designing Integrity-Compatible Circularity

Healthcare-credible circular strategies prioritise:

Upstream Design

✔ Reduce material intensity
✔ Prefer mono-materials where feasible
✔ Avoid blends blocking recovery

Use-Phase Value Retention

✔ Extend durability and lifespan

End-of-Life Realism

✔ Specify actual recovery pathways
✔ Recognise incineration-dominant flows as linear

Leakage Mitigation

✔ Address microfibre release
✔ Integrate filtration / laundering controls where appropriate

Circularity must be systemically achievable, not symbolically declared.

Governance Reframing

Healthcare leaders should shift from asking:

“Is this recycled?”

to:

“Does this intervention strengthen safety, lifecycle recovery, and environmental outcomes?”

Because:

✔ Recycled inputs do not guarantee circular flows
✔ Circular claims do not guarantee integrity
✔ Sustainability metrics do not guarantee sustainability performance

Conclusion

Circularity in healthcare is neither straightforward nor purely technical.

It is constrained by:

• clinical safety
• contamination control
• regulatory frameworks
• infrastructure realities
• human factors

From a systems integrity perspective:

Circularity must be demonstrated at the system level, not inferred from recycled material claims.

Otherwise, organisations risk mistaking improved optics for improved outcomes.

References

Benyathiar, P. et al. (2022) ‘Polyethene terephthalate (PET) bottle-to-bottle recycling’, Polymers, 14(12).

Changing Markets Foundation (2023) Spinning Greenwash.

SYSTEMIQ (2023) Circular PET and Polyester Report.

UNEP (2019) Fashion’s Tiny Hidden Secret.

UNEP (2022) Single-use Face Masks and Alternatives.

Hasan, M. et al. (2023) ‘PPE-derived plastic pollution’, open access article.

European Commission (2022) EU Strategy for Sustainable and Circular Textiles.